Custom RNA shots aim to reboot cancer Patients' immune systems
NCT ID NCT05264974
Summary
This early-stage trial is testing a new, personalized vaccine made from a patient's own tumor. The goal is to see if this vaccine can help the patient's immune system recognize and fight their cancer, especially when standard immunotherapy has stopped working. The study will enroll 18 adults with advanced melanoma or soft tissue sarcoma to check the vaccine's safety and if it can be reliably made.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Florida
RECRUITINGGainesville, Florida, 32608, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.